800 filings
Page 4 of 40
8-K
VNDA
Vanda Pharmaceuticals Inc
27 Jul 23
Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:06pm
4
Kevin Patrick Moran
20 Jun 23
Vanda Pharmaceuticals / Kevin Patrick Moran ownership change
4:34pm
144
Kevin Patrick Moran
15 Jun 23
Notice of proposed sale of securities
6:02pm
4
Timothy Williams
15 Jun 23
Vanda Pharmaceuticals / Timothy Williams ownership change
4:20pm
144
Timothy Williams
13 Jun 23
Notice of proposed sale of securities
8:29pm
4
Ward Anne Sempowski
12 Jun 23
Vanda Pharmaceuticals / Anne Sempowski Ward ownership change
4:20pm
4
VNDA
Vanda Pharmaceuticals Inc
12 Jun 23
Vanda Pharmaceuticals / Stephen Ray Mitchell ownership change
4:19pm
4
Tage Honore
12 Jun 23
Vanda Pharmaceuticals / Tage Honore ownership change
4:19pm
4
VNDA
Vanda Pharmaceuticals Inc
12 Jun 23
Vanda Pharmaceuticals / RICHARD W DUGAN ownership change
4:18pm
4
Chrousos Phaedra
12 Jun 23
Vanda Pharmaceuticals / Phaedra Chrousos ownership change
4:17pm
S-8
VNDA
Vanda Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees
4:46pm
8-K
VNDA
Vanda Pharmaceuticals Inc
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:40pm
8-K
VNDA
Vanda Pharmaceuticals Inc
11 May 23
Other Events
7:01am
EFFECT
VNDA
Vanda Pharmaceuticals Inc
8 May 23
Notice of effectiveness
12:15am
S-3/A
VNDA
Vanda Pharmaceuticals Inc
3 May 23
Shelf registration (amended)
5:10pm
10-Q
2023 Q1
VNDA
Vanda Pharmaceuticals Inc
Quarterly report
3 May 23
4:55pm
8-K
VNDA
Vanda Pharmaceuticals Inc
3 May 23
Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results
4:05pm
CORRESP
VNDA
Vanda Pharmaceuticals Inc
3 May 23
Correspondence with SEC
12:00am
ARS
2022 FY
VNDA
Vanda Pharmaceuticals Inc
24 Apr 23
Annual report to shareholders
5:18pm
DEFA14A
VNDA
Vanda Pharmaceuticals Inc
24 Apr 23
Additional proxy soliciting materials
5:16pm